# Kowa Research Institute, Inc. clinical trials: 47 (2026)

ClinicalTrials.gov lists 47 trials with Kowa Research Institute, Inc. as lead sponsor, 1 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Kowa Research Institute, Inc.: 47 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/kowa-research-institute-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 47
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 47, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 16, 2026 | NCT07650201 | Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction... | Kowa Research Institute, Inc. | Not applicable | Recruiting | Aphakia, Postcataract | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650201) |
| July 29, 2024 | NCT06525311 | A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated... | Kowa Research Institute, Inc. | Phase 1 | Completed | Primary Biliary Cholangitis, Compensated Cirrhosis | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06525311) |
| February 8, 2024 | NCT06247735 | Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate... | Kowa Research Institute, Inc. | Phase 2 | Completed | Primary Biliary Cholangitis | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06247735) |
| April 24, 2023 | NCT05826353 | A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants... | Kowa Research Institute, Inc. | Phase 3 | Completed | Fuchs Endothelial Corneal Dystrophy | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05826353) |
| April 3, 2023 | NCT05795699 | A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal... | Kowa Research Institute, Inc. | Phase 3 | Completed | Fuchs Endothelial Corneal Dystrophy | 107 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05795699) |
| February 10, 2023 | NCT05722262 | Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets... | Kowa Research Institute, Inc. | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05722262) |
| September 6, 2022 | NCT05528172 | A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery | Kowa Research Institute, Inc. | Phase 3 | Completed | Corneal Edema After Cataract Surgery | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05528172) |
| June 3, 2022 | NCT05403827 | A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease | Kowa Research Institute, Inc. | Phase 3 | Completed | Dry Eye Disease | 644 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05403827) |
| April 14, 2022 | NCT05327127 | Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis | Kowa Research Institute, Inc. | Phase 2 | Completed | NASH | 228 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05327127) |
| February 8, 2021 | NCT04742218 | Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers | Kowa Research Institute, Inc. | Phase 1 | Completed | Healthy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04742218) |
| July 23, 2020 | NCT04484428 | A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in... | Kowa Research Institute, Inc. | Phase 2 | Terminated | Acute Pain | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04484428) |
| June 25, 2020 | NCT04447820 | Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR | Kowa Research Institute, Inc. | Phase 2 | Completed | Dyslipidemia | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04447820) |
| January 31, 2020 | NCT04250207 | Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis | Kowa Research Institute, Inc. | Phase 2 | Completed | Fuchs' Endothelial Corneal Dystrophy | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04250207) |
| January 23, 2020 | NCT04237597 | Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers | Kowa Research Institute, Inc. | Phase 1 | Completed | Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04237597) |
| September 10, 2019 | NCT04084483 | A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease | Kowa Research Institute, Inc. | Phase 2 | Completed | Dry Eye Disease | 238 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04084483) |
| October 19, 2018 | NCT03712241 | Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults | Kowa Research Institute, Inc. | Phase 1 | Completed | Healthy | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03712241) |
| October 11, 2018 | NCT03702673 | Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults. | Kowa Research Institute, Inc. | Phase 1 | Completed | Healthy | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03702673) |
| April 23, 2018 | NCT03505567 | Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 | Kowa Research Institute, Inc. | Not applicable | Completed | Glaucoma, Retinal Disease, Healthy | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03505567) |
| March 7, 2017 | NCT03071692 | Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) | Kowa Research Institute, Inc. | Phase 3 | Terminated | Type2 Diabetes, Dyslipidemia | 10,544 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03071692) |
| January 5, 2017 | NCT03011450 | Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal... | Kowa Research Institute, Inc. | Phase 3 | Completed | Severe Hypertriglyceridemia | 471 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03011450) |
| December 23, 2016 | NCT03001817 | Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function | Kowa Research Institute, Inc. | Phase 3 | Completed | Severe Hypertriglyceridemia | 551 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03001817) |
| October 4, 2016 | NCT02922465 | Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult... | Kowa Research Institute, Inc. | Phase 1 | Completed | Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02922465) |
| June 15, 2016 | NCT02799758 | Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia | Kowa Research Institute, Inc. | Phase 3 | Withdrawn | Hyperlipidemia, Dyslipidemia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02799758) |
| March 25, 2016 | NCT02719431 | Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics... | Kowa Research Institute, Inc. | Phase 1 | Completed | Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02719431) |
| February 8, 2016 | NCT02676830 | Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312 | Kowa Research Institute, Inc. | Phase 1 | Completed | Dyslipidemia | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02676830) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 19 |
| Phase 2 | 9 |
| Phase 3 | 10 |
| Phase 4 | 7 |
| Not applicable | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 41 |
| Terminated | 3 |
| Withdrawn | 2 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Dyslipidemias | 7 |
| Hyperlipidemias | 4 |
| Fuchs' Endothelial Dystrophy | 3 |
| Liver Cirrhosis, Biliary | 2 |
| Dry Eye Syndromes | 2 |
| Hypertriglyceridemia | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Intermittent Claudication | 1 |
| Peripheral Arterial Disease | 1 |
| Aphakia, Postcataract | 1 |
| Atherosclerosis | 1 |
| Carotid Artery Diseases | 1 |
| Renal Insufficiency | 1 |
| Sprains and Strains | 1 |
| Glaucoma | 1 |
| Retinal Diseases | 1 |
| Acute Pain | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Research institutes in the United States](https://specstream.ai/data/businesses/research-institutes/united-states)
- [Nursing services in the United States](https://specstream.ai/data/businesses/nursing-services/united-states)
- [Animation studios in the United States](https://specstream.ai/data/businesses/animation-studios/united-states)
- [Gastropubs in the United States](https://specstream.ai/data/businesses/gastropubs/united-states)
- [Roofing contractors in the United States](https://specstream.ai/data/businesses/roofing-contractors/united-states)
- [Caribbean restaurants in the United States](https://specstream.ai/data/businesses/caribbean-restaurants/united-states)
